Meta may invest over $10B in Scale AI as it doubles down on training smarter machine-learning models across its platforms. Scale AI, already backed by Meta, may soon be valued at $25B; Meta eyes deeper AI push with new teams and $65B AI budget. Ready to turn the market's comeback into steady ...

U.S. stocks were mixed, with the Dow Jones index falling around 150 points on Monday. Shares of Warner Bros. Discovery, Inc. WBD rose sharply in today's session.

LEHI, Utah, June 09, 2025 ( GLOBE NEWSWIRE ) -- Nature's Sunshine Products, Inc.

Roth conversions can reduce long-term tax exposure, but timing and execution are key. Tax diversification offers flexibility amid shifting tax laws and retirement income needs. We believe personalized planning beats blanket advice when managing wealth through retirement.

Crypto ETFs have attracted billions in inflows and mainstream attention, but they undermine crypto's core values of decentralization, self-custody and financial empowerment.

June 6, 2025 records indicate that Representative Gilbert Ray Cisneros filed a purchase of Johnson & Johnson JNJ, valued between $39,025 and $410,000. According to the June filing, the transaction occurred on May 30, 2025. Currently, Johnson & Johnson shares are trading down 0.19% at $154.74.

Intuit INTU has outperformed the market over the past 15 years by 10.46% on an annualized basis producing an average annual return of 22.29%. Currently, Intuit has a market capitalization of $213.66 billion.

In today's fast-paced and competitive business landscape, it is essential for investors and industry enthusiasts to thoroughly analyze companies before making investment decisions. In this article, we will conduct a comprehensive industry comparison, evaluating Microsoft MSFT against its key ...

Matador Resources's MTDR short percent of float has risen 3.95% since its last report. The company recently reported that it has 9.99 million shares sold short, which is 9.47% of all regular shares that are available for trading.

76% of patients in the Dupixent trial reached ≥75% improvement in eczema severity at 24 weeks. Sanofi has tripled Beyfortus production and doubled manufacturing sites since its 2023 launch. Get the Strategy to Trade Pre-Fed Setups and Post-Fed Swings-Live With Chris Capre on Wednesday, June 11.